The Latest Breaking News on Mental health

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

Recent lecanemab trials are reason for hope, although health services may struggle to deliver treatments, says dementia researcher Jonathan Schott

The face of the consultant neurosurgeon told me the story before he even pronounced his diagnosis.

A ground-breaking drug has been found to slow cognitive decline in people with Alzheimer’s - with experts hailing it a breakthrough that “can meaningfully change the course of the disease”.

Tokyo (AFP) - Experts hailed full data Wednesday showing a new drug can slow cognitive decline in Alzheimer's patients, but warned improvements were comparatively small and the treatment can have serious side effects.

The early stage of the disease occurs before the irreversible dementia stage and is the golden window for intervention and treatment

The findings suggest a simple urine test could be used to identify people who are in the early stages of the disease.

‘This is the first drug that provides a real treatment option,’ says leading researcher

Antibody therapy lecanemab removes clumps of protein called beta amyloid that builds up in brain

Letter: Linda Saltwell of ADHD Aware says many people realise they need a referral only when they trip over information themselves

"Family accounts starkly illustrate how failings by an individual practitioner, and by the system, led to deep human impacts and resulting harm"